(Q38530013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

review article

1 reference

title

Clinical features and correct diagnosis of macrophage activation syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Francesca Minoia

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Angelo Ravelli

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Sergio Davi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

16 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Clinical Immunology

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

1043-1053

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

Macrophage activation syndrome: advances towards understanding pathogenesis

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Genetic defects in cytolysis in macrophage activation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Novel mutation in STXBP2 prevents IL-2-induced natural killer cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Chimeric antigen receptor T cells for sustained remissions in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Macrophage activation syndrome and cytokine-directed therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Macrophage activation syndrome in the acute phase of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Kawasaki disease: late cardiovascular sequelae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

A clinical perspective of IL-1β as the gatekeeper of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Life-threatening complications of adult-onset Still's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Translational enhancement of H-ferritin mRNA by interleukin-1 beta acts through 5' leader sequences distinct from the iron responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Hypocomplementemia associated with macrophage activation syndrome in systemic juvenile idiopathic arthritis and adult onset still's disease: 3 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Macrophage activation syndrome in Kawasaki disease: more common than we thought?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Recognition and management of macrophage activation syndrome in juvenile arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Ferritinemia as an indicator of systemic disease activity in children with systemic juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

A web-based delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

How I treat hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Immunotherapy of Familial Hemophagocytic Lymphohistiocytosis With Antithymocyte Globulins: A Single-Center Retrospective Report of 38 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.1058159

10.1586/1744666X.2015.1058159

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26082353%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference